Trial Profile
Pharmacokinetic Study in Patients With Unresectable Hepatocellular Carcinoma (HCC) Receiving Treatment With LifePearl Microspheres Loaded With Doxorubicin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Terumo
- 23 Jan 2020 Status changed from active, no longer recruiting to completed.
- 06 Oct 2019 Planned End Date changed from 1 Oct 2018 to 1 Nov 2019.
- 18 Oct 2018 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.